Clay Siegall, Seagen CEO (Dimitrios Kambouris/Getty Images for Gabrielle's Angel Foundation)
May 9, 2022 03:17 PM EDTUpdated 03:35 PM
People
Pharma

Seagen CEO Clay Sie­gall was placed on leave af­ter an April 23 ar­rest for do­mes­tic vi­o­lence gross mis­de­meanor

Kyle LaHucik

Senior Reporter

Clay Sie­gall was placed on leave from his posts as CEO and chair­man of promi­nent Seat­tle-area biotech Seagen af­ter an ar­rest by the Ed­monds Po­lice …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

No­vo Nordisk’s once-dai­ly he­mo­phil­ia drug Al­he­mo ap­proved in US

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Bris­tol My­er­s' TYK2 in­hibitor suc­ceeds in pair of Phase 3 pso­ri­at­ic arthri­tis tri­als

A service from the Financial Times